Evidence gap analysis
Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation
Recent news and posts
Rapid HTAs of two medical devices released in Tuscany
The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 20315 of September 9, 2024, Tuscany Regional Healthcare published two new rapid HTA reports of medical devices in the orthopedics and surgical procedures areas.
The assessed technologies are provided below:
- Trevira tubular band (by Implantcast) for muscles and tendons for oncological patients undergoing limb salvage and prosthetic revision surgery, particularly in the proximal femur and humerus replacements;
- Anti-adhesion barrier Seprafilm (by Genzyme) for patients undergoing emergency surgery, trauma surgery, pelvic surgery, esophagogastric, pancreatic, and colorectal cancer surgery to reduce the incidence, extent, and severity of postoperative adhesions at the site of application.
See the regional decree and all assessments in Italian and English here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.